---
figid: PMC11019011__fphar-15-1370900-g005
pmcid: PMC11019011
image_filename: fphar-15-1370900-g005.jpg
figure_link: /pmc/articles/PMC11019011/figure/F5/
number: FIGURE 5
figure_title: ''
caption: Role of the MAPK signaling pathway in osteoporosis. Advanced glycation end
  products, AGEs; runt-related transcription factor 2, Runx2; SAPK/Erk kinase 1, SEK1;
  Jun N-terminal kinase, JNK; mitogen-activated protein kinase kinase, MEK; mitogen-activated
  protein kinase kinase kinase, MEKK1; extracellular signal-regulated kinases, ERK;
  transforming growth factor-Î²-activated kinase 1, TAK1; MAP kinase kinase-3, MKK3;
  C-terminal telopeptide of type I collagen, CTX1; tartrate-resistant acid phosphatase
  isoform 5b, TRAP5b; dickkopf-1, Dkk1; anti-human t-lymphocyte globulin 1, ATG1;
  nuclear factor of activated T-cells 1, NFATC1; and interleukin, IL.
article_title: 'Traditional Chinese medicine in osteoporosis: from pathogenesis to
  potential activity.'
citation: Gang Cao, et al. Front Pharmacol. 2024;15:1370900.
year: '2024'

doi: 10.3389/fphar.2024.1370900
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.

keywords:
- osteoporosis
- pathogenesis
- pathogenic factors
- traditional Chinese medicine
- treatment

---
